Levomilnacipran Extended-Release Approved for Major Depressive Disorder

Levomilnacipran Extended-Release Approved for Major Depressive Disorder
On July 25, the FDA approved levomilnacipran extended-release (ER) capsules (Fetzima, Forest Laboratories, Inc.) for treatment of major depressive disorder (MDD) in adults. A selective serotonin and norepinephrine reuptake inhibitor, levomilnacipran ER … Read more on Pharmacy Practice News

Depressed? Treatment Not Working? Be Careful What You Do Next
The unfortunate fact is that, if you are being treated for depression by a doctor who is not a mental health professional — a primary care physician, a cardiologist, an oncologist, etc. — the chances are that your doctor has very limited experience … Read more on Huffington Post

Prozac Anti Depressant Drug Verses a Natural Remedy
Fluoxetine is an approved pharmaceutical drug for the treatment of major depression. Types of depression include pediatric depression among other ailments associated with depreciation and panic disorder symptoms. Fluoxetine remains the most popular … Read more on Guardian Express